Iaso Ventures — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Catena develops a conjugation platform for antibody-drug conjugates (ADCs) and multi-payload conjugates used in oncology for solid tumors.
BiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Marco Lobba(Founder)inMatthew Francis(Founder)in
Co-investorsCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Y CombinatorAxial VCLongeVCMBX Capital+1 more
Ryght AI provides an artificial intelligence-powered platform that uses digital twin technology to help clinical research organizations and sponsors identify and select optimal sites for clinical trials.
AI & Machine LearningBiotechHealthtechMedical Devices
Dr. Chadi Nabhan(Chief Medical Officer)Tom Pike(President and Chief Executive Officer)
Co-investorsAIX VenturesFoothill VenturesPage One VenturesVirtue VenturesLDV PartnersTop Harvest Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.